United States · FDA National Drug Code directory
PEMIGATINIB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70277-503_459f8cfd-0f68-de18-e063-6294a90afafd
- Product NDC
- 70277-503
- Form
- TABLET
- Composition / generic term
- PEMIGATINIB
- Labeler
- Lonza Tampa LLC
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20200420
- Source listing expiry
- 20261231
Source-listed ingredients
- PEMIGATINIB — 13.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 TABLET in 1 BOTTLE (70277-503-02) · 70277-503-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →